Patrick Trucchio
Stock Analyst at H.C. Wainwright
(4.98)
# 58
Out of 4,690 analysts
1236
Total ratings
62.4%
Success rate
40.3%
Average return
Main Sectors:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VYGR Voyager Therapeutics | Reiterated: Buy | $25 | $3.54 | +606.21% | 29 | Aug 27, 2026 | |
| AIM: FARN Faron Pharmaceuticals Oy | Reiterated: Buy | 1,000p | 40p | +2,400.00% | 28 | Aug 27, 2026 | |
| NRXP NRx Pharmaceuticals | Reiterated: Buy | $45 | $3.55 | +1,167.61% | 13 | Aug 26, 2026 | |
| GOSS Gossamer Bio | Reiterated: Buy | $2 | $0.1701 | +1,075.78% | 51 | Aug 26, 2026 | |
| BEAM Beam Therapeutics | Reiterated: Buy | $80 | $29.32 | +172.85% | 29 | Aug 25, 2026 | |
| DRUG Bright Minds Biosciences | Reiterated: Buy | $145 | $72.81 | +99.15% | 15 | Aug 21, 2026 | |
| ATAI AtaiBeckley | Reiterated: Hold | $7.5 | $7.29 | +2.88% | 57 | Aug 21, 2026 | |
| ONCY Oncolytics Biotech | Reiterated: Buy | $10 → $5 | $0.8566 | +483.70% | 51 | Aug 20, 2026 | |
| MRKR Marker Therapeutics | Reiterated: Buy | $10 | $1.37 | +629.93% | 8 | Aug 20, 2026 | |
| HELP Cybin | Reiterated: Buy | $70 | $12.18 | +474.71% | 45 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $34.07 | +46.76% | 15 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.9645 | +936.81% | 39 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $55 | $35.13 | +56.56% | 21 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $3.11 | +543.09% | 50 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $13.42 | +458.87% | 43 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $35.32 | +69.88% | 10 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $13.17 | +165.76% | 3 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $40.98 | +70.82% | 45 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $7.78 | +671.21% | 67 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $39.21 | +40.27% | 28 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $36.62 | +173.07% | 53 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $33.84 | +77.30% | 3 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $10.83 | +84.67% | 67 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $6.91 | +623.59% | 22 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $27.94 | +132.64% | 40 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 → $120 | $84.91 | +41.33% | 72 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $65 | $13.73 | +373.42% | 61 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $485 → $455 | $237.10 | +91.90% | 77 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $48.72 | +64.20% | 62 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.1605 | - | 51 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $10 | $1.16 | n/a | 34 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $360 | $15.03 | n/a | 14 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $12.47 | n/a | 5 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.06 | n/a | 5 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 100p → 46p | 6p | n/a | 3 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €33.00 | €3.35 | n/a | 10 | Mar 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $66 → $24 | $43.73 | n/a | 2 | Nov 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 → $130 | $13.60 | n/a | 3 | Sep 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $117 → $72 | $14.48 | n/a | 2 | Nov 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $4.13 | n/a | 1 | Apr 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $20.97 | n/a | 1 | Apr 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $125 | $109.55 | n/a | 1 | Dec 23, 2014 |
Voyager Therapeutics
Aug 27, 2026
Reiterated: Buy
Price Target: $25
Current: $3.54
Upside: +606.21%
Faron Pharmaceuticals Oy
Aug 27, 2026
Reiterated: Buy
Price Target: 1,000p
Current: 40p
Upside: +2,400.00%
NRx Pharmaceuticals
Aug 26, 2026
Reiterated: Buy
Price Target: $45
Current: $3.55
Upside: +1,167.61%
Gossamer Bio
Aug 26, 2026
Reiterated: Buy
Price Target: $2
Current: $0.1701
Upside: +1,075.78%
Beam Therapeutics
Aug 25, 2026
Reiterated: Buy
Price Target: $80
Current: $29.32
Upside: +172.85%
Bright Minds Biosciences
Aug 21, 2026
Reiterated: Buy
Price Target: $145
Current: $72.81
Upside: +99.15%
AtaiBeckley
Aug 21, 2026
Reiterated: Hold
Price Target: $7.5
Current: $7.29
Upside: +2.88%
Oncolytics Biotech
Aug 20, 2026
Reiterated: Buy
Price Target: $10 → $5
Current: $0.8566
Upside: +483.70%
Marker Therapeutics
Aug 20, 2026
Reiterated: Buy
Price Target: $10
Current: $1.37
Upside: +629.93%
Cybin
Aug 20, 2026
Reiterated: Buy
Price Target: $70
Current: $12.18
Upside: +474.71%
Aug 18, 2026
Reiterated: Buy
Price Target: $50
Current: $34.07
Upside: +46.76%
Aug 18, 2026
Reiterated: Buy
Price Target: $10
Current: $0.9645
Upside: +936.81%
Aug 18, 2026
Reiterated: Buy
Price Target: $50 → $55
Current: $35.13
Upside: +56.56%
Aug 17, 2026
Reiterated: Buy
Price Target: $20
Current: $3.11
Upside: +543.09%
Aug 14, 2026
Reiterated: Buy
Price Target: $75
Current: $13.42
Upside: +458.87%
Aug 14, 2026
Reiterated: Buy
Price Target: $60
Current: $35.32
Upside: +69.88%
Aug 14, 2026
Reiterated: Buy
Price Target: $35
Current: $13.17
Upside: +165.76%
Aug 13, 2026
Reiterated: Buy
Price Target: $70
Current: $40.98
Upside: +70.82%
Aug 12, 2026
Reiterated: Buy
Price Target: $60
Current: $7.78
Upside: +671.21%
Aug 12, 2026
Reiterated: Buy
Price Target: $55
Current: $39.21
Upside: +40.27%
Aug 12, 2026
Reiterated: Buy
Price Target: $100
Current: $36.62
Upside: +173.07%
Aug 11, 2026
Reiterated: Buy
Price Target: $60
Current: $33.84
Upside: +77.30%
Aug 10, 2026
Reiterated: Buy
Price Target: $20
Current: $10.83
Upside: +84.67%
Aug 10, 2026
Reiterated: Buy
Price Target: $50
Current: $6.91
Upside: +623.59%
Aug 10, 2026
Reiterated: Buy
Price Target: $65
Current: $27.94
Upside: +132.64%
Aug 7, 2026
Reiterated: Buy
Price Target: $115 → $120
Current: $84.91
Upside: +41.33%
Aug 7, 2026
Reiterated: Buy
Price Target: $70 → $65
Current: $13.73
Upside: +373.42%
Aug 4, 2026
Reiterated: Buy
Price Target: $485 → $455
Current: $237.10
Upside: +91.90%
Jul 30, 2026
Reiterated: Buy
Price Target: $80
Current: $48.72
Upside: +64.20%
Jun 9, 2026
Rated: Hold
Price Target: n/a
Current: $0.1605
Upside: -
Apr 2, 2025
Maintained: Buy
Price Target: $25 → $10
Current: $1.16
Upside: n/a
May 15, 2023
Maintained: Buy
Price Target: $20 → $360
Current: $15.03
Upside: n/a
Feb 10, 2023
Rated: Hold
Price Target: n/a
Current: $12.47
Upside: n/a
Feb 10, 2023
Rated: Hold
Price Target: n/a
Current: $0.06
Upside: n/a
Nov 2, 2022
Reiterated: Buy
Price Target: 100p → 46p
Current: 6p
Upside: n/a
Mar 27, 2020
Maintained: Buy
Price Target: €33.00
Current: €3.35
Upside: n/a
Nov 8, 2019
Downgraded: Hold
Price Target: $66 → $24
Current: $43.73
Upside: n/a
Sep 18, 2019
Maintained: Buy
Price Target: $120 → $130
Current: $13.60
Upside: n/a
Nov 13, 2018
Downgraded: Hold
Price Target: $117 → $72
Current: $14.48
Upside: n/a
Apr 19, 2018
Initiated Coverage: Buy
Price Target: $25
Current: $4.13
Upside: n/a
Apr 19, 2018
Initiated Coverage: Buy
Price Target: $22
Current: $20.97
Upside: n/a
Dec 23, 2014
Upgraded: Buy
Price Target: $125
Current: $109.55
Upside: n/a